Veeva Systems today announced that Amgen plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade. Announced in Pleasanton, California, the agentic CRM foundation will help accelerate the delivery of innovative medicines to patients worldwide.
"Moving to Vault CRM will help accelerate our efforts to bring new therapies to patients globally with greater speed and agility," said Scott Skellenger, senior vice president and chief information officer at Amgen. "Veeva's deep understanding of life sciences, its continued focus on innovation, and our long-standing collaboration will help support Amgen in achieving these important goals."
"Vault CRM will provide the agentic commercial foundation to help Amgen deliver innovative medicines for some of the world's toughest diseases to millions of patients," said Matt Farrell, president, commercial strategy at Veeva. "We look forward to supporting Amgen as it launches important new therapies worldwide."
Vault CRM is part of the Vault CRM Suite, the technology foundation for agentic commercial, transforming how the industry engages with healthcare professionals to accelerate launch performance and improve patient outcomes. It includes the Agentic Call Report to generate Commercial Evidence and uncover previously hidden treatment barriers.
The global deployment builds on Veeva's deep understanding of life sciences and continued focus on innovation, supporting Amgen's goal to deliver innovative medicines for some of the world's toughest diseases.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
